| P50 | author | Nathalie Rouas-Freiss | Q87819345 |
| P2093 | author name string | Didier Samuel | |
| | Antoine Durrbach | |
| | Severine Beaudreuil | |
| P2860 | cites work | Chronic renal failure after transplantation of a nonrenal organ | Q28204928 |
| | Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases | Q28285089 |
| | Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group | Q28374428 |
| | Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 |
| | Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data | Q31036557 |
| | Corticosteroid administration depresses circulating dendritic cells in ITP patients | Q33365235 |
| | HLA-G inhibits the transendothelial migration of human NK cells | Q58836918 |
| | A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity | Q58853391 |
| | RENAL TRANSPLANT PATIENT COMPLIANCE WITH FREE IMMUNOSUPPRESSIVE MEDICATIONS1 | Q59746844 |
| | IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo | Q60700622 |
| | Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts | Q62618489 |
| | Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation | Q62735509 |
| | A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin | Q72672810 |
| | Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells | Q73612987 |
| | What is trogocytosis and what is its purpose? | Q73866035 |
| | Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation | Q73937145 |
| | Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation | Q74528702 |
| | Influence of cytokine genotypes on allograft rejection | Q74571356 |
| | Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production | Q77372678 |
| | Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation | Q78021267 |
| | Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells | Q78408699 |
| | Autoimmune hepatitis following liver transplantation: relationship to recurrent disease and steroid weaning | Q78693521 |
| | Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients | Q79259079 |
| | Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection | Q81121285 |
| | Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis | Q81359843 |
| | Combination treatment with donor-specific transfusions and cyclosporine a induces long-term survival of cardiac allografts in miniature Swine | Q81546072 |
| | Clinical operational tolerance after kidney transplantation | Q82837584 |
| | Immunopharmacology: anti-inflammatory therapy targeting transcription factors | Q33709280 |
| | The role of costimulatory molecules as targets for new immunosuppressives in transplantation | Q33901145 |
| | HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis | Q33941618 |
| | Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. | Q34269503 |
| | Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine | Q34421471 |
| | STEALTH matters: a novel paradigm of durable primate allograft tolerance | Q34487772 |
| | Sirolimus for Kaposi's sarcoma in renal-transplant recipients | Q34556363 |
| | The extent and analysis of cytokine and cytokine receptor gene polymorphism | Q34823945 |
| | Sirolimus in liver transplantation | Q35125781 |
| | Cell‐cycle regulation of T‐cell responses – novel approaches to the control of alloimmunity | Q35583494 |
| | Prope tolerance: the future of organ transplantation--from the laboratory to the clinic | Q35743065 |
| | The concept of "partial" clinical tolerance | Q35893649 |
| | Tacrolimus in liver transplantation | Q36181372 |
| | CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness | Q36370807 |
| | A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance | Q37388089 |
| | Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes | Q40327449 |
| | Predictors of improvement in renal function after calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction | Q40441702 |
| | Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial | Q40657873 |
| | Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture | Q40830294 |
| | Tolerogenic immunosuppression for organ transplantation | Q41116219 |
| | A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features | Q41177624 |
| | Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation | Q41689014 |
| | Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance | Q41704139 |
| | Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. | Q42640095 |
| | Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). | Q42673427 |
| | Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial | Q43710489 |
| | Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study | Q43738507 |
| | Mycophenolate mofetil monotherapy in liver transplantation | Q43738516 |
| | End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment | Q43843805 |
| | HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes | Q44062284 |
| | Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients | Q44486217 |
| | High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells | Q44580638 |
| | Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance | Q44620458 |
| | Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice | Q44913829 |
| | The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors | Q45017496 |
| | Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. | Q45035165 |
| | Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation | Q45119325 |
| | Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression | Q45219600 |
| | Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results | Q46589176 |
| | An investigation of polymorphism in the interleukin-10 gene promoter | Q48054541 |
| | Tracking the immunoregulatory mechanisms active during allograft tolerance | Q49022949 |
| | Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans, and Anglo-Americans. | Q50980110 |
| | Effective membrane model of the immunological synapse. | Q51729856 |
| | Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation. | Q53593857 |
| | A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. | Q54125455 |
| | CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 |
| P433 | issue | 2 | |
| P921 | main subject | liver transplantation | Q1368191 |
| P304 | page(s) | 98-107 | |
| P577 | publication date | 2006-12-11 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation? | |
| P478 | volume | 17 | |